❭ Research by medical division ❭ Cancer Medicine ❭ Department of Oncology ❭ Cellular therapy ❭

Innovations and Technologies Licencing and partnering

We have some technologies available for exclusive licensing or industrial collaboration. Our TTO (Inven2) will answer all your questions about:  

  • Dual CAR IGK-CD19

 

 

  • CAR against osteosarcoma, OSCAR

 

 
Scroll to top

Home Department of Oncology Cellular therapy

  • News
  • Contact Translational Research Unit
  • Contact Clinical Ward
  • CellFit
  • Publications
  • Vacant positions
  • External collaborators
  • Centre for Advanced Cell Therapy (ACT)

Recent publications

Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S (2025)
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors
Cell Rep Med, 102350 (in press)
DOI 10.1016/j.xcrm.2025.102350, PubMed 40925376

Sæbøe-Larssen S, Sioud M (2025)
Enhancing Cancer Vaccine Efficacy: siRNA-Based Modulation of Immune Suppressive Factors in Dendritic Cells
Methods Mol Biol, 2965, 259-273
DOI 10.1007/978-1-0716-4742-4_12, PubMed 40877509

Hønnåshagen TK, Skoge LJ, Sæbøe-Larssen S, Håkenstad H, Kvalheim G, Sioud M (2025)
Production of mRNA-Loaded Dendritic Cell Cancer Vaccines
Methods Mol Biol, 2965, 245-258
DOI 10.1007/978-1-0716-4742-4_11, PubMed 40877508

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)